Minna M. Koskenvuo
Haartmaninkatu 4, PL 372
Helsinki, 00029, Finland
Helsinki, 00029, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Evaluating Pediatric Reference Ranges for Extended Immunophenotyping from a Finnish Cohort against Published References.
Journal: Journal of clinical immunology
Published: May 06, 2025
Graft-Versus-Host Disease Sustains Coagulation Activity for two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: February 05, 2025
Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.
Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.
Journal: British journal of haematology
Published: January 20, 2025
Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation.
Journal: Immunology and cell biology
Published: November 23, 2023
Impact of newborn screening for SCID on the management of congenital athymia.
Journal: The Journal of allergy and clinical immunology
Published: June 11, 2023
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Journal: Journal of clinical immunology
Published: May 02, 2022
Sleep-related breathing disorder in non-infectious pulmonary complications after pediatric allogeneic stem cell transplantation.
Journal: Pediatric research
Published: February 28, 2022
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients.
Journal: Bone marrow transplantation
Published: February 25, 2022
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N.
Journal: Frontiers in pediatrics
Published: December 15, 2021
Last Updated: 09/26/2026